| |
|
|
|
Rigel Pharmaceuticals  
|
|
2.6 -0.09 (-0.03%) |
10-19 16:00 |
|
Open: |
2.69 |
Pre close: |
2.69 |
Target:
|
3.39
|
|
High: |
2.79 |
Low: |
2.56 |
Resistance:
|
2.90
3.39
|
|
Volume: |
2,621,147 |
Market Cap: |
439M |
Support:
|
2.45
2.17
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.64
 |
MACD |
MACD(12,26):
|
0.06  |
|
MA(20): |
2.46 |
Signal(12,26,9): |
0.04 |
|
MA(100): |
2.34 |
Stochastic Oscillator |
%K(14,3):
|
80.63 |
|
MA(250): |
2.16 |
%D(3): |
85.86 |
|
Average Volume(K) |
3-Month: |
314336
|
52-Week |
High:
|
5.24 |
|
10-Days: |
207747 |
Low: |
1.23 |
|
RSI |
RSI(14):
|
56.32 |
Change(%): |
53.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.149 |
Return on Equity (ttm) |
-35.4 |
Shares Out. (M) |
168.93 |
|
EPS Est. Current Year |
-0.600 |
Return on Assets (ttm) |
-10.9 |
Shares Float (M) |
168.41 |
|
EPS Est. Next Year |
-0.430 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.31 |
|
EPS Est. Next Quarter |
-0.150 |
Qtrly Rev. Growth |
53.9 |
% Held by Institutions |
90.42 |
|
Forward EPS |
-0.400 |
Gross Profit (p.s.) |
0.033 |
Shares Short (K) |
9930 |
|
Book Value (p.s.) |
0.370 |
EBITDA (p.s.) |
-0.148 |
P/E |
-17.45 |
|
Sales Per Share |
0.640 |
Qtrly Earnings Growth |
0.00 |
P/BV |
7.03 |
|
Profit Margin |
-23.16 |
Operating Cash Flow
(M) |
-41.42 |
P/S |
4.07 |
|
Operating Margin |
-23.82 |
Levered Free Cash Flow
(M) |
-13.30 |
P/CF |
-10.60 |
|
|
|
|
|
|
